Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.
about
Application of radiation technology in vaccines developmentRapid development of image analysis research tools: Bridging the gap between researcher and clinician with pyOsiriX.Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.Radiogenomics: radiobiology enters the era of big data and team science.The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinomaImpending Challenges for the Use of Big Data.How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry Enables Multiplex, Quantitative Pharmacodynamic Studies of Phospho-Signaling.Impact of single-nucleotide polymorphisms on radiation pneumonitis in cancer patients.Personalized Radioproteomics: Identification of a Protein Biomarker Signature for Preemptive Rescue by Tocopherol Succinate in CD34(+) Irradiated Progenitor Cells Isolated from a Healthy Control Donor.Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma.Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM.Non-homologous end-joining protein expression screen from radiosensitive cancer patients yields a novel DNA double strand break repair phenotype.Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment.ERCC2 polymorphisms and radiation-induced adverse effects on normal tissue: systematic review with meta-analysis and trial sequential analysis.Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?Identification of radiation response genes and proteins from mouse pulmonary tissues after high-dose per fraction irradiation of limited lung volumes.Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply.Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer.Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy.Motivation for the inclusion of genetic risk factors of radiosensitivity alongside dosimetric and clinical parameters in predicting normal tissue effects.Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer.Lethal outcome after pelvic salvage radiotherapy in a patient with prostate cancer due to increased radiosensitivity : Case report and literature review.Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity.
P2860
Q26798165-E5BE40A2-8C7E-4AB5-8D0C-05673DC890E3Q27317305-996C6162-DD3B-4DDC-A8D0-867612B1265FQ30234489-1FD41AE2-4162-4EEC-8B16-EF2D0D97C86AQ30833608-493E4887-047F-4B5C-89B4-4199A4AF9956Q33648870-9234FE0A-5F08-495A-927E-53202293C142Q35900743-854E4DDE-BF64-45A6-A318-303A128E1703Q35900753-D2D39573-D272-4044-9F64-E3228DB98B54Q35926217-982F0E95-93E7-47D5-B3BB-A505AE13694EQ36502969-5F262777-4BB7-4B1F-A44B-F2349FA7FD1BQ36802901-181FAD4E-335A-419B-9BE3-14FBE49F9749Q36898448-89E06B94-A3B4-4C0D-83F3-32CA8E6EF0C8Q37696169-265CC7D4-87B7-4535-BF3A-1E5457DCB3BDQ37705828-E6CE6414-5234-4EF1-B5F6-AD1515249064Q37714343-ADB5AAFA-EA05-4700-BC17-7990A48AA0FDQ38325595-D51F1A20-6734-4BF8-A24A-15FC88B20710Q38655709-70935CBB-8734-44A7-84F2-E3FD1AC4F822Q38761174-9DE4463D-EB41-4A15-8DAE-1251AC1678CCQ39373612-14AE8FD5-11B3-4021-859E-2D7C529FE51DQ43081709-6F417E68-219D-4B21-86BD-B8E2A0C0B721Q47109602-B419FF3F-44E3-4295-B2B2-32E1BB04B09DQ47344087-160D3A6C-72EB-402F-B8D5-5D7FBF3DA811Q47684929-D6E06CA5-FBFF-48C9-B4BB-AB737554CEEBQ49834246-41ED7DB7-583E-463E-8190-8E6BF65BAA68Q50193292-517E6F8F-B7D0-4151-9A27-4BCD3EEF5866Q50491249-86278077-AA1C-4652-89FE-42F1B96441BB
P2860
Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Radiogenomics: using genetics ...... ffects following radiotherapy.
@en
Radiogenomics: using genetics ...... ffects following radiotherapy.
@nl
type
label
Radiogenomics: using genetics ...... ffects following radiotherapy.
@en
Radiogenomics: using genetics ...... ffects following radiotherapy.
@nl
prefLabel
Radiogenomics: using genetics ...... ffects following radiotherapy.
@en
Radiogenomics: using genetics ...... ffects following radiotherapy.
@nl
P2093
P2860
P1433
P1476
Radiogenomics: using genetics ...... ffects following radiotherapy.
@en
P2093
Barry S Rosenstein
Harry Ostrer
Sarah L Kerns
P2860
P304
P356
10.1158/2159-8290.CD-13-0197
P577
2014-01-17T00:00:00Z